Someone is going to have to pay higher prices, Michelle Gibley says as trade deals raise tariffs – either U.S. companies, or the U.S. consumer. She warns that we haven’t seen tariffs on pharmaceuticals and expresses concern about potential deals with Canada and China. She charts how deeply foreign companies’ GDP depends on exporting to the U.S. and notes that many are looking to diversify away from the U.S. Michelle also explores how a lower U.S. dollar is impacting the situation.